Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets

Clinical trial NCT07172126 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07172126
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2025-09-01
Primary completion: 2027-04-01
Enrollment: 291

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.